Along with OPV withdrawal, an appropriate containment of eradicated polioviruses is a key objective of the Polio Eradication and Endgame Strategic Plan 2013-2018. Containment of polioviruses, as laid out in GAPIII, is taking place in 3 phases linked to global milestones in polio eradication. Current (Phase 1) activities are focused on containment of WPV2 and VDPV2, as well as on preparation for containment of vaccine polioviruses of type 2 (OPV/Sabin2). To support this process, WHO/Europe organized a poliovirus biorisk management training course on 17–20 May 2016 in Copenhagen, Denmark for representatives from all 13 Member States in the European Region intending to keep type 2 wild poliovirus (WPV2) or vaccine-derived poliovirus (VDPV2) materials for research or vaccine manufacturing purposes. More information can be found here.